Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. artery stent
Show results for
Products
Services
Software
Applications

Companies

News
Articles

Refine by
Date

  • Older

Artery Stent Articles & Analysis

7 news found

Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE Transcarotid Stent System

Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE Transcarotid Stent System

” About Silk Road Medical’s TCAR Procedure with the ENROUTE Transcarotid Neuroprotection and Stent System TransCarotid Artery Revascularization is our clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing ...

BySilk Road Medical, Inc.


InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS

InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS

(Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces the initiation of enrollment and successful completion of the first cases of the Company’s U.S. registration C-Guardian trial of CGuard EPS. The first patients, who were under ...

ByInspireMD Inc.


First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting

First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting

Nearly 20,000 patients were included (14,979 CEA and 4,993 TCAR) from the VQI CEA and carotid artery stent (CAS) registries over a 4-year time period (August 2016 to August 2020). ...

BySilk Road Medical, Inc.


Revacept - an innovative vascular plaster proved in coronary heart disease

Revacept - an innovative vascular plaster proved in coronary heart disease

With Revacept severe complications such as heart attacks and stroke in combination with bleedings were rarer than with the standard therapy Aspirin and Clopidogrel in patients with coronary artery disease. Revacept seals the lesion in a blood vessel like a plaster. ...

ByadvanceCOR GmbH


B. Braun Interventional Systems Inc., an Affiliate of B. Braun Medical Inc., and Infraredx, a Nipro Company, Announce Strategic U.S. Collaboration to Execute the IDE Clinical Trial for the SeQuent Please ReX Drug Coated PTCA Balloon Catheter

B. Braun Interventional Systems Inc., an Affiliate of B. Braun Medical Inc., and Infraredx, a Nipro Company, Announce Strategic U.S. Collaboration to Execute the IDE Clinical Trial for the SeQuent Please ReX Drug Coated PTCA Balloon Catheter

Braun Group of Companies and Japan-based Nipro Corporation to advance coronary artery disease management. The companies are ideally positioned to leverage shared resources to accelerate the initiation of the U.S. clinical trial of the SeQuent Please ReX to study the treatment of coronary in-stent restenosis (ISR), which is defined as the gradual re-narrowing of ...

ByInfraredx, Inc.


ELIXIR MEDICAL ANNOUNCES COMMENCEMENT OF INFINITY-SWEDEHEART RANDOMIZED CONTROLLED TRIAL OF DYNAMX CORONARY BIOADAPTOR SYSTEM

ELIXIR MEDICAL ANNOUNCES COMMENCEMENT OF INFINITY-SWEDEHEART RANDOMIZED CONTROLLED TRIAL OF DYNAMX CORONARY BIOADAPTOR SYSTEM

This has been associated with MACE.5 Studies have shown adverse event rates associated with DES of 20 percent at five years2 and 40 to 50 percent at 10 years.3 Published papers have demonstrated that a DES prevents positive adaptive remodeling,6 inhibits vessel compliance and dilation in response to the body’s changing blood flow needs,7,8 and causes vessel straightening, which has been ...

ByElixir Medical Corporation


Imperial Innovations Set to Increase Investment in Veryan Medical

Imperial Innovations Set to Increase Investment in Veryan Medical

The helical curvature also helps the stented vessel mimic the natural biomechanical performance of the femoropopliteal artery during knee flexion, thereby reducing the risk of stent fracture and vessel kinking, which are common problems with traditional straight stents. ...

ByVeryan Medical Ltd.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT